Si­en­na Bio bags $65M in the lat­est suc­cess­ful biotech IPO

Bustling along with a pipeline of ther­a­pies for var­i­ous skin con­di­tions, Si­en­na Bio­phar­ma­ceu­ti­cals has raised about $65 mil­lion from its IPO af­ter pric­ing 4.3 mil­lion shares at $15. Un­der­writ­ers have an op­tion on an­oth­er 650,000 shares.

Si­en­na’s start­ing price is right in the mid­dle of the range it set for it­self, mark­ing an­oth­er suc­cess­ful out­ing in a string of biotech IPOs over the last two months.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER